Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. (2023)

First Author: Eleftheriou D

Attributed to: Syndromic infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-07051-9

PubMed Identifier: 36703139

Publication URI: http://europepmc.org/abstract/MED/36703139

Type: Journal Article/Review

Volume: 24

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215